InsiderTrades

Form 4 for BIO BIO-RAD LABORATORIES, INC.

Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-08 · accession 0001062993-23-006320 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-08 2023-03-08 BIO ERNST TIMOTHY S EVP, GC, Sec M - OptEx $167.82 +1,000 4,267 +31% +$167.8K
DM 2023-03-08 2023-03-08 BIO ERNST TIMOTHY S EVP, GC, Sec S - Sale+OE $486.43 -1,746 2,671 -40% -$849.3K
DM 2023-03-08 2023-03-08 BIO ERNST TIMOTHY S EVP, GC, Sec M - OptEx $0.00 -1,000 2,350 -30% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Bio-Rad A Common Stock 2023-03-08 M A 150 $215.98 4,417.36 D — —
2 Common Bio-Rad A Common Stock 2023-03-08 S D 1,000 $486.08 3,417.36 D — —
3 Common Bio-Rad A Common Stock 2023-03-08 S D 746 $486.89 2,671.36 D — —
4 Common Bio-Rad A Common Stock 2023-03-08 M A 850 $159.32 4,267.36 D — — (F1) Includes 12.1510 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022.
5 Derivative Non-Qualified Stock Option (right to buy) 2023-03-08 M D 850 $0.00 0 D $159.32 · — to 2026-09-07 850 Bio-Rad A Common Stock (F2) The option, representing a right to purchase a total of 2,500 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted.
6 Derivative Non-Qualified Stock Option (right to buy) 2023-03-08 M D 150 $0.00 2,350 D $215.98 · — to 2027-09-05 150 Bio-Rad A Common Stock (F3) The option, representing a right to purchase a total of 2,500 shares, became exercisable in five equal annual installments beginning on September 5, 2018, which was the first anniversary of the date on which the option was granted.